Industry Insights
Pushing the Boundaries of Translational Molecular Imaging
Industry InsightProfessor Ron Heeren recently embarked on a study to bring together the spatial molecular information that is provided by MALDI-MSI with the microproteomic characterization generated by LC-MS on the same tissue specimen, on a single instrument. Heeren and colleagues were successful in this feat. Their work is published in the journal Proteomics and forms the basis of this interview.
Read More
Engineering Innovative CAR T-Cell Therapy Candidates for Cancer
Industry InsightTechnology Networks recently had the pleasure of speaking with Celyad Oncology’s CEO Filippo Petti. In this interview, Petti discusses key immunotherapy advances, highlights the two main CAR T-cell therapy approaches and elaborates on the company’s “off-the-shelf” CAR T cells.
Read More
Using Organoids in the Study of Infectious Diseases
Industry InsightBy providing greater physiologic relevance and a species- or patient-specific test platform, organoids overcome many limitations of conventional 2D cultures and even live-animal disease models.
Read More
Progress in Companion Diagnostic Development for Low-Grade Glioma
Industry InsightTo learn about the benefits of accelerating turnaround times for genomic testing and the importance of partnering with pharma companies to develop companion diagnostics, Technology Networks spoke with Luca Quagliata, PhD, BCMAS, Global Director of Medical Affairs for Thermo Fisher Scientific.
Read More
Breaking Down Barriers in Proteomic-Based Drug Discovery
Industry InsightSomaLogic recently announced an agreement with the biopharmaceutical company Amgen that aims to advance Amgen's drug discovery and development programs through comprehensive proteomic profiling. We spoke with Roy Smythe to discover what barriers have been holding proteome analysis back, and how the collaboration with Amgen aims to change the landscape of drug discovery.
Read More
Biomaterial-Based Vaccine That Sits Under the Skin Shows Promise Against SARS-CoV-2
Industry InsightA team of multidisciplinary scientists – including bioengineers, materials-scientists and immunologists – at the Wyss Institute has created a novel infection vaccine platform know as OmniVax. Technology Networks spoke with Lead Senior Staff Scientist Ed Doherty from the Wyss Institute for Biologically Inspired Engineering at Harvard University, to learn more.
Decoding the Immune System
Industry InsightOur immune system is incredibly complex. Developing a complete understanding is an enormous undertaking but one to which scientists have been striving in order to advance disease understanding and improve treatments.
Read More
Blood Test Detects Over 50 Different Cancers With a 0.7% False-Positive Rate
Industry InsightEarlier this year, researchers reported in Annals of Oncology that they had developed a blood test that was able to detect, with 99.3% specificity, more than 50 types of cancer and identify exactly where in the body the cancer had originated – in some cases before any symptoms of the disease had manifested. We spoke to the study’s corresponding author, Michael V. Seiden MD PhD, to learn more.
Read More
Driving Speed, Sensitivity and Precision in Modern Proteomics
Industry InsightTechnology Networks spoke with Rohan Thakur, Executive Vice President of Life Sciences Mass Spectrometry at Bruker Daltonics, to discuss the company's latest analytical technologies and their capabilities.
Read More
Taking a Closer Look at Trends in Microscopy
Industry InsightWith advances in cellular and tissue-based imaging, researchers are able to peel back the layers on new challenges and test hypotheses to solve more problems. We heard about some of the advancements being made in the field of confocal microscopy.
Read More
